Netris Pharma Is A Clinical Stage Biopharmaceutical Company Based In Lyonfrancefounded In 2006It Focuses On Developing Innovative Therapies That Target Cancer Resistance Mechanismsparticularly Through The Role Of Netrin 1A Protein Linked To Cancer Cell Survival And Treatment Resistancethe Company Is A Spin Off From The Centre La On Ba Rarda Prominent Cancer Research Center The Lead Productnp137Is A First In Class Monoclonal Antibody Currently In Clinical Development For Various Solid Tumorsit Has Been Administered To Over 300 Patientsshowing A Strong Safety Profile And Anti Tumor Activitynetris Pharma Is Also Exploring A New Programendonetherapyaimed At Treating Endometriosis By Targeting Netrin 1 Overexpressionthe Company Has Raised A 24 4 Million In Funding To Support Its Clinical Trials And Corporate Growthand It Collaborates With Partners Like Msd And Orano To Enhance Its Research Efforts
No conferences found for this company.
| Company Name | Netris Pharma Sas |
| Country |
France
|
| Address | N/A |
| Telephone | N/A |
| N/A |
